Institute For Research In Biomedicine is a Swiss private company located in Bellinzona that provides biomedicine research and development services.\nThe company says this about itself: Founded in 2000 in Bellinzona, the IRB is affiliated with the Università della Svizzera italiana, since 2010. IRB hosts 13 research groups studying defense mechanisms to fight infections, tumors and degenerative diseases. With more than 630 publications in main scientific journals, the IRB has gained international recognition as a center of excellence for immunology and cell biology. Molinari’s laboratory investigates the protein quality control processes determining whether a polypeptide should be secreted, retained in the ER, or selected for degradation. Particular emphasis is given to the study of select rare diseases such as a1-antitrypsin deficiency, LSDs and Charcot-Marie-Tooth 1B neuropathy.

Zydus Lifesciences Ltd. engages in the discovery, development, and manufacture of pharmaceutical products under Zydus brand. The firm's products portfolio includes active pharmaceutical ingredients, human formulations, and animal health & veterinary. It operates through the following segments: Pharmaceuticals and Consumer Products. The Pharmaceuticals segment represents the business of integrated pharmaceutical operations with business encompassing the entire value chain in the research, development, production, marketing and distribution of pharmaceutical products. The Consumer Products segment represents the business of development, production, marketing, and distribution of differentiated health and wellness products. The company was founded by Ramanbhai B. Patel in 1952 and is headquartered in Ahmedabad, India.

UAB Research Foundation (doing business as UABRF), a subsidiary of The University of Alabama System, is a company headquartered in Birmingham, AL. The firm engages in identify, assess, and market commercially viable technology developed at The University of Alabama at Birmingham.

Aridis Pharmaceuticals discovers and develops anti-infectives to be used as add-on treatments to standard-of-care antibiotics. The company is utilizing its proprietary ʎPEXTM and MabIgX technology platforms to rapidly identify rare, potent antibody-producing B-cells from patients who have successfully overcome infection and to rapidly manufacture monoclonal antibodies (mAbs) for the therapeutic treatment of critical infections. These mAbs are already of human origin and functionally optimized for high potency by the donor's immune system; hence, they technically do not require genetic engineering or further optimization to achieve full functionality.

Morinaga & Co., Ltd. engages in the manufacture, purchase, and sale of confectioneries. It operates through the following business segments: Food Manufacturing, Food Merchandise and Restaurant, Real Estate and Services, and Others. The Food Manufacturing segment manufactures and distributes confectioneries, foodstuffs, frozen desserts, and health products. The Food Merchandise and Restaurant segment involves with the operation of restaurants. The Real Estate and Services segment deals with real estate business and operation of golf courses. The Others segment includes the manufacture and sale of research reagents. The company was founded by Taichiro Morinaga on August 15, 1899 and is headquartered in Tokyo, Japan.

BioInvent is a research-based pharmaceutical company developing innovative antibody drugs targeting cancers with unmet clinical need.Our drug development programmes are supported by our human antibody development platform. This consists of a proprietary antibody library, n-CoDeR:registered:, and in-house technology for the rapid selection, screening and identification of antibodies with excellent affinity and selectivity for targets. BioInvent has a high level of competence in antibody drug discovery, preclinical and clinical development. The Company also has many years' experience in process development and antibody manufacturing, which we carry out at our own facilities. Alongside our in house and partnered drug-development programmes we offer antibody discovery and development services to customers. BioInvent's business model and technology platform have been validated through numerous partnerships. These include a co-development agreement with Bayer, Daiichi Sankyo, Mitsubishi Tanabe, Servier and others. BioInvent employs around 50 people and is based in Lund, Sweden. The Company listed on the NASDAQ OMX Stockholm in 2001.

HTI Bio Products, Inc. manufactures of custom and proprietary antibody products and services. The company was founded by Michael Dale and Robert J. Harman in 1990 and is headquartered in San Diego, CA.

Qyuns Therapeutics Co., Ltd. engages in the innovation and production of antibody drugs for the treatment of immune-related diseases and therapeutic antibody drugs. Its therapeutic areas include skin diseases, inflammatory rheumatic, inflammatory bowel, and inflammatory respiratory. The company was founded by Wen Wan Qiu on June 16, 2015 and is headquartered in Taizhou, China.

Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA.

Makes systems for blood and cell analysis

ToolGen, a biotechnology company, focuses on the development of genome editing technology. Its products include gRNA/Cas9 purified that provides ready-to-use reagents for genome engineering experiments; gRNA/Cas9 plasmid that offers tools for genome editing experiment; and recombinant Cas9 protein that offers ready-to-use reagents for genome engineering experiments. ToolGen also offers genome-edited cell line; genome-edited mouse/rat; and genome-edited plant services, as well as surrogate reporter synthesis and in-del analysis services. Its products are used in research applications. ToolGen began operation in 1999, with its headquarters in Seoul in South Korea. ToolGen is a subsidiary of NSN.

Serum Institute of India Pvt. Ltd. is the vaccine manufacturer by number of doses produced and sold globally (more than 1.3 billion doses) which includes Polio vaccine as well as Diphtheria, Tetanus, Pertussis, Hib, BCG, r-Hepatitis B, Measles, Mumps and Rubella vaccines. It is estimated that about 65% of the children in the world receive at least one vaccine manufactured by Serum Institute. Vaccines manufactured by the Serum Institute are accredited by the World Health Organization, Geneva and are being used in around 140 countries across the globe in their national immunization programs, saving millions of lives throughout the world.

GenBody, Inc. engages in developing raw materials for diagnostic use such as ELISA and rapid diagnostic tests. The company was founded by Jeong Jeom-Gyu on October 17, 2012 and is headquartered in Cheonan, South Korea.

Janssen Biotech, Inc. has delivered on the promise of new treatments and new ways to improve the health of individuals with serious disease. Built upon a rich legacy of innovative "firsts," Janssen Biotech, Inc. pursues innovative solutions in the therapeutic areas of immunology, oncology, and nephrology. With the same unwavering passion for new challenges, They dedicate ourselves to delivering solutions for these disease states where unmet needs continue to exist.

Henan Sinot Biotechnology Co., Ltd., established on 2010-10-18, Business scope includes production:No.I,No.IIclass of medical devices:6840Clinical laboratory analysis instruments and in vitro diagnostic reagents;Sales:Class III medical devices:6840Clinical laboratory analysis instruments and in vitro diagnostic reagents;second category:Medical Optics,Instruments and endoscopic equipment6822;Clinical Laboratory Analytical Instruments6840(Contains in vitro diagnostic reagents);Medical testing and basic equipment6841;Disinfection and sterilization equipment and utensils6857;medical cold therapy,low temperature,Refrigeration equipment and appliances6858;software6870;No.Iclass of medical devices,Inspection equipment,Analytical Instruments,Laboratory instruments and related reagents,Consumables Research,Sales,Technical Services;Research and technical services of in vitro diagnostic reagents and consumables;biotechnology research;Engaged in the import and export of goods and technology;Leasing of medical equipment.

The Institut national de la recherche agronomique (INRA, pronounced [inʁa]; English: National Institute of Agricultural Research) is a French public research institute dedicated to agricultural science. It was founded in 1946 and is a Public Scientific and Technical Research Establishment under the joint authority of the Ministries of Research and Agriculture.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

NCPC New Drug Research & Development Co. Ltd., a subsidiary of Province of Hebei, is a Chinese company located in Shijiazhuang. The firm manufactures and distributes medicines.

Shanghai Taiyin Biotechnology Co., Ltd., established on 2010-08-04, Business scope includes biological products,Development of Pharmaceutical Products,Chemical raw materials and products(Removal of hazardous chemicals,Monitor Chemicals,civilian explosives,precursor chemicals),Pharmaceutical Intermediates(In addition to drugs)development,Sales,laboratory consumables,Instrumentation,Sales of Electronics,And provide technology transfer in related fields,technical consulting,Technical Services. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]